BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos.
Animals
Asbestos
Biomarkers, Tumor
/ metabolism
Carcinogenesis
Cell Nucleus
/ metabolism
Female
Gene-Environment Interaction
Germ-Line Mutation
HMGB1 Protein
/ chemistry
Heterozygote
Histone Deacetylase 1
/ chemistry
Incidence
Inflammation
Male
Mesothelioma
/ metabolism
Mice
Mutation
Prognosis
Protein Binding
Tumor Suppressor Proteins
/ chemistry
Ubiquitin
/ chemistry
Ubiquitin Thiolesterase
/ chemistry
HMGB1
asbestos
gene × environment
germline BAP1 mutations
mesothelioma
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
30 11 2021
30 11 2021
Historique:
accepted:
15
10
2021
entrez:
24
11
2021
pubmed:
25
11
2021
medline:
28
12
2021
Statut:
ppublish
Résumé
Carriers of heterozygous germline
Identifiants
pubmed: 34815344
pii: 2111946118
doi: 10.1073/pnas.2111946118
pmc: PMC8640737
pii:
doi:
Substances chimiques
BAP1 protein, mouse
0
Biomarkers, Tumor
0
HMGB1 Protein
0
HMGB1 protein, mouse
0
Tumor Suppressor Proteins
0
Ubiquitin
0
Asbestos
1332-21-4
Ubiquitin Thiolesterase
EC 3.4.19.12
Hdac1 protein, mouse
EC 3.5.1.98
Histone Deacetylase 1
EC 3.5.1.98
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA198138
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA237235
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES030948
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA214195
Pays : United States
Déclaration de conflit d'intérêts
Competing interest statement: M.C. has a patent issued for BAP1. M.C. and H.Y. have two patents issued for HMGB1. M.C. is a board-certified pathologist who provides consultation for pleural pathology, including medical–legal.
Références
Annu Rev Immunol. 2011;29:139-62
pubmed: 21219181
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10214-9
pubmed: 10954737
Br J Ind Med. 1992 Aug;49(8):566-75
pubmed: 1325180
Clin Cancer Res. 2007 May 15;13(10):2836-48
pubmed: 17504981
Sci Rep. 2016 Mar 10;6:22850
pubmed: 26961782
Nat Rev Immunol. 2005 Apr;5(4):331-42
pubmed: 15803152
PLoS One. 2012;7(4):e34318
pubmed: 22496788
Mol Cell. 2021 Sep 2;81(17):3526-3541.e8
pubmed: 34186021
Nat Rev Dis Primers. 2016 May 26;2:16035
pubmed: 27226234
Immunol Rev. 2017 Nov;280(1):74-82
pubmed: 29027228
Cancer Sci. 2012 Sep;103(9):1714-21
pubmed: 22703527
J Clin Gastroenterol. 2013 Sep;47(8):684-8
pubmed: 23685846
Nat Commun. 2014 Oct 06;5:5128
pubmed: 25283999
Nat Cell Biol. 2018 Oct;20(10):1181-1192
pubmed: 30202049
Am J Pathol. 2013 Nov;183(5):1654-66
pubmed: 24160326
Nature. 2014 Mar 6;507(7490):109-13
pubmed: 24572365
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25543-25552
pubmed: 32999071
Cell Death Differ. 2018 Nov;25(11):1885-1904
pubmed: 30323273
J Clin Oncol. 2018 Oct 30;:JCO2018790352
pubmed: 30376426
Nat Rev Cancer. 2013 Mar;13(3):153-9
pubmed: 23550303
J Thorac Oncol. 2015 Apr;10(4):565-76
pubmed: 25658628
PLoS One. 2014 Feb 14;9(2):e87915
pubmed: 24551070
Lancet Oncol. 2015 Apr;16(4):447-56
pubmed: 25800891
PLoS One. 2014 Apr 10;9(4):e94523
pubmed: 24722339
Nucleic Acids Res. 2017 Jul 3;45(W1):W365-W373
pubmed: 28521030
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):285-90
pubmed: 24347639
Cancer Discov. 2020 Aug;10(8):1103-1120
pubmed: 32690542
Nature. 2012 Aug 30;488(7413):670-4
pubmed: 22801494
Oncogene. 2016 Apr 14;35(15):1996-2002
pubmed: 26119930
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611-6
pubmed: 20616036
Oncotarget. 2017 Apr 4;8(14):22649-22661
pubmed: 28186988
Cell Death Dis. 2015 Jun 11;6:e1786
pubmed: 26068794
Mol Cell Biol. 2010 Nov;30(21):5071-85
pubmed: 20805357
J Biol Chem. 1979 Nov 25;254(22):11577-83
pubmed: 500660
Mol Med. 2015 Jun 18;21:526-35
pubmed: 26101955
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3068-73
pubmed: 24469805
Nat Rev Cancer. 2020 Sep;20(9):533-549
pubmed: 32472073
J Phys Chem B. 2017 Apr 20;121(15):3473-3482
pubmed: 27797194
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12351-6
pubmed: 12209006
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13432-13437
pubmed: 27834213
J Biol Chem. 2010 Dec 17;285(51):39888-97
pubmed: 20937823
EMBO Rep. 2002 Oct;3(10):995-1001
pubmed: 12231511
Nature. 2017 Jun 22;546(7659):549-553
pubmed: 28614305
J Cell Biol. 2010 Sep 6;190(5):881-92
pubmed: 20819940
J Mol Biol. 2007 Dec 7;374(4):993-1004
pubmed: 17964600
CA Cancer J Clin. 2019 Sep;69(5):402-429
pubmed: 31283845
Mol Oncol. 2018 Mar;12(3):322-338
pubmed: 29316268
Science. 2019 Apr 19;364(6437):283-285
pubmed: 31000662
Cancer Res. 2004 Aug 1;64(15):5518-24
pubmed: 15289363
Nucleic Acids Res. 2020 Sep 18;48(16):8993-9006
pubmed: 32710624
Nature. 2002 Jul 11;418(6894):191-5
pubmed: 12110890
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13618-23
pubmed: 21788493
Ann Thorac Surg. 1995 Apr;59(4):835-44
pubmed: 7695406
J Phys Chem B. 2012 Jul 26;116(29):8494-503
pubmed: 22545654
Cell Death Differ. 2017 Oct;24(10):1694-1704
pubmed: 28665402
EMBO J. 2003 Oct 15;22(20):5551-60
pubmed: 14532127
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S39-S46
pubmed: 32206569
Cancer Res. 2012 Jul 1;72(13):3290-301
pubmed: 22552293